CONMED Corp. (CNMD)
51.48
+0.42
(+0.81%)
USD |
NYSE |
Aug 24, 16:00
51.48
0.00 (0.00%)
After-Hours: 20:00
CONMED Enterprise Value : 2.328B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.328B |
| August 20, 2026 | 2.338B |
| August 19, 2026 | 2.334B |
| August 18, 2026 | 2.274B |
| August 17, 2026 | 2.274B |
| August 14, 2026 | 2.309B |
| August 13, 2026 | 2.291B |
| August 12, 2026 | 2.281B |
| August 11, 2026 | 2.284B |
| August 10, 2026 | 2.280B |
| August 07, 2026 | 2.270B |
| August 06, 2026 | 2.289B |
| August 05, 2026 | 2.275B |
| August 04, 2026 | 2.308B |
| August 03, 2026 | 2.352B |
| July 31, 2026 | 2.185B |
| July 30, 2026 | 2.206B |
| July 29, 2026 | 2.093B |
| July 28, 2026 | 2.124B |
| July 27, 2026 | 2.102B |
| July 24, 2026 | 2.077B |
| July 23, 2026 | 2.034B |
| July 22, 2026 | 2.056B |
| July 21, 2026 | 2.053B |
| July 20, 2026 | 2.100B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.092B |
| July 16, 2026 | 2.147B |
| July 15, 2026 | 2.080B |
| July 14, 2026 | 2.049B |
| July 13, 2026 | 2.069B |
| July 10, 2026 | 1.951B |
| July 09, 2026 | 1.897B |
| July 08, 2026 | 1.804B |
| July 07, 2026 | 1.824B |
| July 06, 2026 | 1.850B |
| July 02, 2026 | 1.811B |
| July 01, 2026 | 1.779B |
| June 30, 2026 | 1.778B |
| June 29, 2026 | 1.863B |
| June 26, 2026 | 1.910B |
| June 25, 2026 | 1.868B |
| June 24, 2026 | 1.893B |
| June 23, 2026 | 1.845B |
| June 22, 2026 | 1.807B |
| June 18, 2026 | 1.808B |
| June 17, 2026 | 1.794B |
| June 16, 2026 | 1.868B |
| June 15, 2026 | 1.856B |
| June 12, 2026 | 1.874B |
| June 11, 2026 | 1.863B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 11.18B |
| Stryker Corp. | 138.34B |
| Alphatec Holdings, Inc. | 1.956B |
| Baxter International, Inc. | 20.30B |
| Becton, Dickinson & Co. | 68.24B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 23.07M |
| Revenue (Quarterly) | 343.76M |
| Total Expenses (Quarterly) | 320.69M |
| EPS Diluted (Quarterly) | 0.766 |
| Gross Profit Margin (Quarterly) | 55.12% |
| Profit Margin (Quarterly) | 6.71% |
| Earnings Yield | 3.59% |
| Operating Earnings Yield | 9.52% |
| Normalized Earnings Yield | 5.232 |